✦ LIBER ✦

CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain

✍ Scribed by Luz A. Cortes-Burgos; Ben S. Zweifel; Steven L. Settle; Robert A. Pufahl; Gary D. Anderson; Medora M. Hardy; Dana E. Weir; George Hu; Fernando A. Happa; Zachary Stewart; Shanmugam Muthian; Matthew J. Graneto; Jaime L. Masferrer

Book ID: 113588358
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 932 KB
Volume: 617
Category: Article
ISSN: 0014-2999
DOI: 10.1016/j.ejphar.2009.06.058

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

155 PTK787/ZK 222584 (PTK/ZK), a potent

155 PTK787/ZK 222584 (PTK/ZK), a potent orally active and highly selective inhibitor of VEGFR kinases, is highly efficacious in various experimental tumor models either as mono- or combination therapy

✍ H. Hess-Stumpp; M. Haberey; A. Reichel; K.H. Thierauch 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Discovery of potent selective bioavailab

Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: Optimization studies and demonstration of in vivo efficacy

✍ Plummer, Mark S.; Cornicelli, Joseph; Roark, Howard; Skalitzky, Donald J.; Stank 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 1007 KB

Discovery, Synthesis, and Structure–Acti

Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N -4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu 4 ) with Oral Efficacy in an Antiparkinsonian Animal Model

✍ Jones, Carrie K.; Engers, Darren W.; Thompson, Analisa D.; Field, Julie R.; Blob 📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 515 KB